BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7971613)

  • 41. Gastroduodenal mucosal defense.
    Ham M; Kaunitz JD
    Curr Opin Gastroenterol; 2008 Nov; 24(6):665-73. PubMed ID: 19122513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of NSAID-induced gastroenteropathy.
    Price AH; Fletcher M
    Drugs; 1990; 40 Suppl 5():1-11. PubMed ID: 2081486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selection.
    Polisson R
    Am J Med; 1996 Feb; 100(2A):31S-36S. PubMed ID: 8604725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NSAIDs, gastrointestinal injury, and cytoprotection.
    Scheiman JM
    Gastroenterol Clin North Am; 1996 Jun; 25(2):279-98. PubMed ID: 9229573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins.
    Robert A
    Adv Prostaglandin Thromboxane Res; 1976; 2():507-20. PubMed ID: 983858
    [No Abstract]   [Full Text] [Related]  

  • 46. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword.
    Lichtenstein DR; Syngal S; Wolfe MM
    Arthritis Rheum; 1995 Jan; 38(1):5-18. PubMed ID: 7818572
    [No Abstract]   [Full Text] [Related]  

  • 47. Nonsteroidal anti-inflammatory drugs: gastroduodenal injury and beyond.
    Bernsdorff KR; Agrawal RM; Brodmerkel GJ
    Dig Dis; 1995; 13(4):251-66. PubMed ID: 8521610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Lesion of the gastroduodenal mucosa caused by non-steroidal anti-inflammatory drugs (NSAID)].
    Pastor García E
    Aten Primaria; 1990 Jun; 7(6):448, 450-1. PubMed ID: 2129719
    [No Abstract]   [Full Text] [Related]  

  • 49. The NSAIDs and the gastrointestinal mucosa. An update symposium. Oslo, 14 October 1988. Proceedings.
    Scand J Gastroenterol Suppl; 1989; 163():1-73. PubMed ID: 2814362
    [No Abstract]   [Full Text] [Related]  

  • 50. [The adverse digestive effects of nonsteroidal anti-inflammatory agents. Current physiopathological and clinical aspects. I. The adverse effects on the digestive track].
    Duţu A; Parasca I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1990; 42(2):97-109. PubMed ID: 1982193
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of nonsteroidal, antiinflammatory drugs on gastrointestinal injury and prostanoid generation in healthy volunteers.
    Levine RA; Petokas S; Nandi J; Enthoven D
    Dig Dis Sci; 1988 Jun; 33(6):660-6. PubMed ID: 3371138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostaglandins: gastrointestinal effects and peptic ulcer disease.
    Wilson DE; Kaymakcalan H
    Med Clin North Am; 1981 Jul; 65(4):773-87. PubMed ID: 6268904
    [No Abstract]   [Full Text] [Related]  

  • 53. Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence.
    Carson JL; Willett LR
    Drugs; 1993; 46 Suppl 1():243-8. PubMed ID: 7506183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of age, Helicobacter pylori, and NSAID usage on the upper gastrointestinal tract.
    Hui E; Sung J; Leung V; Ling T; Li E; Cheng A; Woo J
    J Am Geriatr Soc; 1996 Aug; 44(8):1010-2. PubMed ID: 8708290
    [No Abstract]   [Full Text] [Related]  

  • 55. Toxicity of nonsteroidal anti-inflammatory drugs.
    Goodwin JS
    Arch Intern Med; 1987 Jan; 147(1):34-5. PubMed ID: 3800525
    [No Abstract]   [Full Text] [Related]  

  • 56. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs: novel gastrointestinal-sparing drugs.
    Bandarage UK; Janero DR
    Mini Rev Med Chem; 2001 May; 1(1):57-70. PubMed ID: 12369991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastrointestinal actions of carbacyclin, a stable mimic of prostacyclin.
    Whittle BJ; Steel G; Boughton-Smith NK
    J Pharm Pharmacol; 1980 Aug; 32(8):603-4. PubMed ID: 6106709
    [No Abstract]   [Full Text] [Related]  

  • 58. Mechanisms of gastric damage by non-steroidal anti-inflammatory drugs.
    Shorrock CJ; Rees WD
    Scand J Rheumatol Suppl; 1989; 78():5-11; discussion 30-2. PubMed ID: 2660253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastric barrier function and toxic damage.
    Niv Y; Banić M
    Dig Dis; 2014; 32(3):235-42. PubMed ID: 24732189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NSAIDs revisited: selection, monitoring, and safe use.
    Amadio P; Cummings DM; Amadio PB
    Postgrad Med; 1997 Feb; 101(2):257-60, 263-7, 270-1. PubMed ID: 9046939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.